Skip to content

Clinical trials

Observational Cardiovascular Diseases trials in Belgium

Search ClinicalTrials.gov registrations by keyword, then narrow by condition, phase, status, country and start year.

Filters: Condition: Cardiovascular Diseases Phase: Observational Country / region: Belgium Clear all

24 trials match Source: ClinicalTrials.gov registrations

Trials started per year

By phase, 2000 to 2026.

Trials started per year
CategoryTrials
20051
20071
20091
20111
20122
20141
20151
20162
20183
20193
20203
20211
20222
20231

Status

Trials by registry status. Select a bar to filter.

Trials by status
CategoryTrials
Completed11
Recruiting5
Unknown status4
Active, not recruiting2
Enrolling by invitation1
Terminated1

Top lead sponsors

A sponsor with a page on Pharma Observatory links to it.

Top lead sponsors
CategoryTrials
Hasselt University3
AstraZeneca1
Bayer1
Boston Scientific Corporation1
Daiichi Sankyo Europe, GmbH, a Daiichi Sankyo Company1
ECRI bv1
Erasme University Hospital1
GlaxoSmithKline1
Heidelberg University1
Institut für Pharmakologie und Präventive Medizin1

Top conditions

MeSH conditions the trials were registered with, not their broader categories. A condition with a page on Pharma Observatory links to it.

Top conditions
CategoryTrials
Cardiovascular Diseases24
Heart Diseases7
Coronary Artery Disease4
Myocardial Ischemia3
Vascular Diseases3
Atherosclerosis2
Diabetes Mellitus2
Dyslipidemias2
Embolism and Thrombosis2
Heart Failure2

Trials

Showing 1 to 24 of 24. Each trial links to its page on Pharma Observatory.

Recently changed trials

Changes observed in the last 7 days, newest first, site-count changes left out. Source: ClinicalTrials.gov.

No changes to these trials in the last 7 days.

Go deeper on Pharma Observatory

Pharma Observatory connects clinical trials, sponsors, sites and investigators in one searchable platform.